Arkolith/Insider Trading/DSGN/Form 4

Shah Pratik

President, CEO and Chairperson, DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Sep 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2023Grant(A)1.1M—$01.1M
Sep 1, 2023Grant(A)525K—$0525K
Sep 1, 2023Grant(A)525K—$0525K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-048222) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML